KAREN CANNIFF: Open Payments
NPI 1578086260 · ALBANY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,033 in 53 payments from 11 companies in 2025. Trend: 2023 $1,724 · 2024 $1,712 · 2025 $1,033
Food & beverage: $1,033
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 24 | $468 |
| PFIZER INC. | 12 | $167 |
| AstraZeneca Pharmaceuticals LP | 6 | $132 |
| BridgeBio Pharma, Inc. | 3 | $74 |
| Cleerly, Inc. | 1 | $50 |
| CVRx, Inc. | 1 | $33 |
| Amgen Inc. | 2 | $28 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $24 |
| E.R. Squibb & Sons, L.L.C. | 1 | $20 |
| Abbott Laboratories | 1 | $19 |
Products named: LEQVIO, ELIQUIS, Attruby, WAINUA, Cleerly Ischemia, LOKELMA, FARXIGA, Barostim Neo System.
Industry payments across NY — which companies pay providers there.
